Basic Information
IR-Med, Inc. is developing a non-invasive spectral analysis technology platform that enables medical professionals to detect and measure molecules in blood and human tissue in real time without any invasive procedures. The company's first product under development is a handheld optical monitoring device, which is being developed to support the early detection of pressure injuries (PI) in skin and underlying tissues.
IR-Med, Inc.
Israel
15~50 people
September 01, 2012
contact@ir-medical.com

